Daniil Gataulin
Stock Analyst at Chardan Capital
(1.1)
# 2048
Out of 5,370 analysts
99
Total ratings
47.83%
Success rate
-3.93%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RGNX Regenxbio | Maintains: Buy | 52 52 | 9.1 | 471.43% | 11 | Jun 9, 2025 | |
QURE uniQure | Maintains: Buy | 38 38 | 14.8 | 156.76% | 4 | May 30, 2025 | |
ADVM Adverum Biotechnolog... | Maintains: Buy | 33 33 | 2.44 | 1252.46% | 7 | May 15, 2025 | |
MGTX MeiraGTx Hldgs | Maintains: Buy | 38 35 | 6.53 | 435.99% | 4 | May 14, 2025 | |
CRVO CervoMed | Maintains: Strong Buy | 14 15 | 7.22 | 107.76% | 6 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 7 | 1.16 | 503.45% | 11 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 33 | 19.27 | 71.25% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 33 27 | 9.35 | 188.77% | 11 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 4 | n/a | n/a | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 70 70 | 18.74 | 273.53% | 2 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 4 | 0.82 | 387.8% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 64 61 | 13.1 | 365.65% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 0.8 | 650% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 3 3 | 1.75 | 71.43% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 220 220 | 2.48 | 8770.97% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 22 13 | n/a | n/a | 2 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Sep 28, 2022 |